Frontlight ResearchEarly access
Trial site
AdventHealth Cancer Institute
- 10running trials
- 4closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Ovarian cancer4 trials
- Gastric and oesophageal cancer3 trials
- Bladder cancer2 trials
- Colorectal cancer2 trials
- Diffuse large B-cell lymphoma2 trials
- Melanoma2 trials
- Metastatic breast cancer2 trials
- Prostate cancer2 trials
- Triple-negative breast cancer2 trials
- Acute myeloid leukaemia1 trial
- Cervical cancer1 trial
- and 9 more
- Phase
- Phase 36 trials
- Phase 13 trials
- Phase 23 trials
- Phase 1/22 trials
- Status
- Recruiting6 trials
- Active, not recruiting4 trials
- Terminated2 trials
- Completed1 trial
- Withdrawn1 trial
- Lead sponsor
- Janssen Research & Development, LLC2 trials
- Seagen Inc.2 trials
- AdventHealth1 trial
- Atara Biotherapeutics1 trial
- Daiichi Sankyo1 trial
- and 7 more
Running trials
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ovarian cancer3 recruiting
- Lung cancer2 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Terminated
Withdrawn
Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy
Terminated
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026